Anthem Blue Cross is collaborating with Stanford to launch the AI for Health Affiliation program, a corporate affiliates program within the Stanford Department of Computer Sciences that will fund research on how AI can improve the efficiency and value of Anthem Blue Cross and its health plans.

Cleveland Clinic this month announced it’s launching a Center for Clinical Artificial Intelligence (CCAI) dedicated to the development and application of AI in medicine.

French pharmaceutical startup Pharnext is leveraging AI and pleiotropy to develop new drug combinations and repurpose existing therapies, Fortune reported March 19.

Radiology patients are confident artificial intelligence will improve healthcare workflow and efficiency, but they’re skeptical of the tech itself and remain unsure of how AI will factor into the patient experience, according to a study published online March 14 in the Journal of the American College of Radiology.

A multitude of recent studies and success stories suggest artificial intelligence is on its way to topping doctors in accurately diagnosing diseases from asthma to breast cancer—seemingly a step in the right direction. But does the hype surrounding AI’s victories eclipse its shortcomings?

Artificial intelligence shows great promise in recognizing patterns, liberating physicians from keyboards and predicting outcomes, but where does it fall short? Medical guru Eric Topol does a deep dive into those topics and many more in his new book, Deep Medicine.

NVIDIA this week announced plans to buy chipmaker and its collaboration partner Mellanox Technologies for $6.9 billion. The move by the graphics chip giant seeks to help it push into the growing market for data center components by adding to chips that help speed the flow of information across servers.